Your browser doesn't support javascript.
loading
Treadmill exercise training prevents myocardial mechanical dysfunction induced by androgenic-anabolic steroid treatment in rats.
Bocalini, Danilo S; Beutel, Abram; Bergamaschi, Cássia T; Tucci, Paulo J; Campos, Ruy R.
Afiliação
  • Bocalini DS; Department of Post Graduation in Physical Education, São Judas Tadeu University, São Paulo, Brazil.
  • Beutel A; Cardiovascular Division, Department of Physiology, Federal University of São Paulo, São Paulo, Brazil.
  • Bergamaschi CT; Cardiovascular Division, Department of Physiology, Federal University of São Paulo, São Paulo, Brazil.
  • Tucci PJ; Department of Medicine. Cardiology division - Federal University of São Paulo - São Paulo, Brazil.
  • Campos RR; Cardiovascular Division, Department of Physiology, Federal University of São Paulo, São Paulo, Brazil.
PLoS One ; 9(2): e87106, 2014.
Article em En | MEDLINE | ID: mdl-24533053
ABSTRACT
Elevated concentrations of testosterone and its synthetic analogs may induce changes in cardiovascular function. However, the effects of the combination of anabolic/androgenic steroid (AAS) treatment and exercise training on systolic and diastolic cardiac function are poorly understood. In the present study, we aimed to investigate the effects of low-dose steroid treatment (stanozolol) on cardiac contractile parameters when this steroid treatment was combined with exercise training in rats and the effects of chronic steroid treatment on the Frank-Starling (length-tension curves) relationship. Male Wistar rats were randomly assigned to one of four groups U (untrained), US (untrained and treated with stanozolol 5 mg/kg/week), T (trained, 16 m/min/1 h) and TS (trained and treated with stanozolol 5 mg/kg/week). Continuous exercise training was conducted 5 days/week for 8 consecutive weeks. The speed of the treadmill was gradually increased to a final setting of 16 m/min/1 h. Experiments were divided into two independent series 1) central hemodynamic analysis for mean arterial blood pressure (MAP) and cardiac output (CO) measurements and 2) isolated papillary muscle preparation in Krebs solution. Stanozolol treatment significantly increased the MAP and the heart size in untrained and trained rats (U 113±2; T 106±2; US 138±8 and TS 130±7 mmHg). Furthermore, stanozolol significantly decreased developed tension and dT/dt (maximal and minimal) in U rats. However, the developed tension was completely restored by training. The Frank/Starling relationship was impaired in rats treated with stanozolol; however, again, training completely restored diastolic function. Taken together, the present data suggest that AAS treatment is able to decrease cardiac performance (systolic and diastolic functions). The combination of stanozolol and physical training improved cardiac performance, including diastolic and systolic functions, independent of changes in central hemodynamic parameters. Therefore, changes in ventricular myocyte calcium transients may play a cardioprotective role.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estanozolol / Teste de Esforço / Coração / Anabolizantes / Miocárdio Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estanozolol / Teste de Esforço / Coração / Anabolizantes / Miocárdio Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article